AZN vs REKR · P/E 28, $288.38B cap vs rev $22.9M
AstraZeneca PLC (AZN) versus Rekor Systems Inc (REKR) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Rekor Systems Inc (REKR) is a software - infrastructure company listed on NASDAQ.
AZN does not have a complete income-statement cache yet.
Latest reported REKR revenue for 2026-06-30 was $22.9M. Net income was -$9.9M. REKR currently screens at market cap $96.5M.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. REKR currently screens at market cap $96.5M.
Not investment advice. Open the AZN and REKR stock pages for the full models.
Not investment advice.